About the Institute

Background

This Institute is a non-profit and privately funded cancer research organisation, founded in 2005 by two former patients of the world renowned Dr John Holt. When Dr Holt retired from treating people with his innovative radiowave therapy in 2004 (after 35 years as a radiotherapist treating cancer patients), it was a case of watching potentially very valuable cancer treatments vanish, or of taking up where Dr Holt left off.

The question you might well ask is, ‘why do you need to research radiowave therapy if Dr Holt was treating people with cancer using these techniques for up to 30 years?’

In part, whilst there are plenty of past patients of Dr Holt who will testify to the efficacy of his treatments, the answer lies in the fact that actual records about treatment outcomes from a bygone time are scarce. Further, Dr Holt was obviously intent on helping people with his treatments, perhaps at the expense of research investment, as it would seem there is a paucity of information about radiowave therapy within the medical industry.

Very rigorous research practices are applied these days before medicines and treatments will be accepted by those who prescribe them. Unfortunately Dr Holt’s treatments suffer from the view by many that this research needs to happen. The Institute recognizes the situation for what it is and has been established to get this research done.

You would think after 30 years of use that radiowave therapy would be regarded as a conventional treatment – especially after it has received so much hype and media. Yet the community remains polarised about the therapies. Stakeholders in this treatment are now quite varied, including the federal government and its health and medical bodies, the cancer patient community, the media, the medical community, researchers, suppliers of medicinal products, probably Dr Holt himself and not least of all, the two investors in the Radiowave Therapy Research Institute.

The one fact remains: the published data needed to take radiowave therapy further than exists today is long overdue.